Before you vote › Federal bills

H.R. 27: HALT Fentanyl Act

119th Congress · introduced 2025-01-03 · Crime and Law Enforcement · Latest: Received in the Senate and Read twice and referred to the Committee on the Judiciary.

federal

Save to my notebook What does this mean? Print

Official title

HALT Fentanyl Act

Plain summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the bill establishes a new, alternative registration process for certain schedule I research. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

Officials and money

Sponsor: Rep. Griffith, H. Morgan [R-VA-9] · 61 cosponsors

Money: No cost estimate published yet. No linked contracts or vendors yet.

Recorded votes

• House roll call 32 (2025): On Agreeing to the Amendment, H R 27 (2025-02-06): Failed
• House roll call 33 (2025): On Passage, H R 27 (2025-02-06): Passed

Sources

• Congressional Research Service summary (Introduced in House)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-119hr27.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/119/hr>

Record fed-us-cong119-hr27 · catalog fed-us-congress-bills-cong119 · updated 2026-11-03 by psicol fed-bills